PLEK2 and non-small cell lung carcinoma: Additionally, PLEK2 expression is upregulated by TGF−β stimulation through ELK1 and Smad2/3 in non-small cell lung cancer and esophageal squamous cell carcinoma, respectively (Wu et al., 2020; Wang et al., 2021).